Docetaxel Injection USP (2019-06-03)
- Starting date:
- June 3, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-70163
Last updated: 2019-07-02
Summary
-
Product:
Docetaxel Injection USP
Reason
The impurity 10-oxo-docetaxel could be out-of-specification in the affected lots.
Depth of distribution
Healthcare establishments
Affected products
Docetaxel Injection USP
DIN, NPN, DIN-HIM
DIN 02361957
Dosage form
Solution
Strength
Docetaxel 10 mg/mL
Lot or serial number
DC31711A, DC31714B
Companies
- Recalling Firm
-
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA
- Marketing Authorization Holder
-
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA